Similarly, there was a significant elevation in Beclin-1 concentrations in the kidneys of the CIS-treated Gal-3 KO mice compared to Gal-3 KO sham control mice, also demonstrating statistical significance (p < 0.001) (Figure 10C). This evidence concerns the gene BECN1 and in situ carcinoma.